Two growth stocks I think could make you richer

These two stocks are thriving despite the weak markets and I think they are poised for enormous growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Falling markets are presenting investors with a lot of buying opportunities but looking for stocks that are still rising can be the best strategy for spotting hidden gems. AB Dynamics (LSE:ABDP) is an advanced vehicle testing company that could grow significantly from its specialisation in self-driving cars. I mentioned it as a good momentum buy back in October and it has gained 11% since then, despite flailing market sentiment in the UK generally.

Big upgrades

Whenever a company boasts in its trading statement for the first six months of the year that results will be “significantly ahead of market expectations” as it did back in October, I think it’s worth taking a closer look. When H1 results were released it revealed revenue increased 51% and earnings-per-share increased 70%, so it didn’t disappoint.

Looking ahead, it is releasing several new products and told us it has strong orders through next year. It is expanding internationally and has indicated that there is growing demand for its vehicle-testing services. Factoring all of this in, I think it is a very exciting time to be holding this share.

But I’m taking a wait and see approach for now. My main reservation currently is that directors have been very busy selling shares recently. While management can’t be faulted for cashing in some profits, the sizes of the holdings are significant. It looks like eight directors in total have offloaded shares with some selling over 50% of their holdings. But Anthony Best (the AB in the company’s name) sold a small amount and still retains over 30% ownership of the company, which is encouraging.

Also it had a new CEO as of October which can signal a change in fortunes so I’d wait for confirmation that progress is continuing before buying.

Growing ahead of demand

Sopheon (LSE:SPE) is a computer software company that has also been thriving recently. It is up 15% since October on the back of a big upgrade in forecasts. It provides software that helps companies produce estimates, and subsequently savings, through lifecycle management.

The trouble with this company is that its revenue guidance makes it very difficult to value. We have to do a bit of puzzle-solving to get an approximate figure. Revenue for 2018 was forecast at $31m (despite being listed on AIM, it reports in dollars) but in its half-year results it was stated that “revenue visibility for the year [is] already at $27.2m”. However it has since stated that it had a record Q3 and that visibility is now above $30m with two new deals in chemicals and electronics. Since then it has released news of an additional contract with The Nature’s Bounty Co. This is a billion dollar health firm so presumably this could have pushed revenue over revised forecasts of $32.5m.

These constant upwards revisions leave a lot of room for speculation, so I would conjecture that revenue will be in the mid-30s. Its deals are large but infrequent, so it would be risky to assume that it will be higher. Regardless of the exact figure, this company is growing so quickly that the share price can’t keep up. With this in mind, I’d consider buying into this company.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Robert Faulkner has no position in any of the shares mentioned. The Motley Fool UK has recommended AB Dynamics. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »